Evaluation of the prototype device for glucose monitoring by oral glucose tolerance test - Evaluation of the prototype device for glucose monitoring by oral glucose tolerance test

APO PLUS STATION CO., LTD.0 sites50 target enrollmentJanuary 30, 2024

Overview

No summary available.

Registry

who.int

Start Date

January 30, 2024

End Date

February 29, 2024

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•1\)Subjects who are on treatment for a serious illness. 2\)Subjects who have been diagnosed with diabetes and under treatment or medication. 3\)Subjects who are may develop allergies in connection with the oral glucose tolerance test. 4\)Subjects who regularly use licensed drugs or quasi\-drugs that may affect the study. 5\)Subjects who are currently on treatment at a medical institution for a disease that may affect the study. 6\)Subjects who are participating in a clinical trial or have participated in another clinical trial within 1 month before the date of consent for this study. 7\)Subjects who are pregnant and those who are breastfeeding. 8\)Subjects who plan to participate in another clinical trial during the study period. 9\)Subjects who have difficulty in wearing the prototype device. 10\)Subjects who have difficulty in wearing continuous glucose monitoring. 11\)Subjects who have difficulty in blood drawing from their fingertips by themselves. 12\)Subjects who judged as unsuitable for this study by the principal investigator for any reasons.